Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
Intangible Assets
Immuneering Corp
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Immuneering Corp
NASDAQ:IMRX
|
Intangible Assets
$379.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Abbvie Inc
NYSE:ABBV
|
Intangible Assets
$62.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
43%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Intangible Assets
$23.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Intangible Assets
$31.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
35%
|
CAGR 10-Years
9%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Intangible Assets
$834.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Intangible Assets
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immuneering Corp's Intangible Assets?
Intangible Assets
379.7k
USD
Based on the financial report for Dec 31, 2023, Immuneering Corp's Intangible Assets amounts to 379.7k USD.
What is Immuneering Corp's Intangible Assets growth rate?
Intangible Assets CAGR 1Y
-5%
Over the last year, the Intangible Assets growth was -5%.